Jane Kirby

A study of 12,409 dementia-free people found that maintaining normal blood pressure, avoiding diabetes and not smoking between ages 45 and 65 was associated with nearly 13 additional years free from dementia compared with having all three risk factors. Participants without these factors had an average of 30.1 dementia-free years from age 55, versus just over 17 years for those with all three. Women and white participants had more dementia-free years than men and Black participants. Researchers and Alzheimer’s Research UK stressed that managing cardiovascular risks may reduce cognitive decline, although no strategy guarantees dementia prevention.

Tracy Tomlinson, a 58-year-old woman with recurrent advanced ovarian cancer, has become the first person worldwide to receive ZI-MA4-1, an experimental off-the-shelf cell therapy, at Manchester’s Christie NHS Foundation Trust. The treatment uses donor natural killer cells engineered with T-cell receptors to target the MAGE-A4 protein found in several cancers. As part of the early-stage Zima-101 trial, it is being tested in ovarian, lung, sarcoma, and head and neck cancers. Clinicians and researchers say the approach could make targeted cell therapies faster and less expensive to produce, although the trial is primarily assessing safety and its effectiveness is not yet known.

Tracy Tomlinson, a 58-year-old Manchester patient with recurrent advanced ovarian cancer, has become the first person worldwide to receive ZI-MA4-1 in a clinical trial at the Christie NHS Foundation Trust. Developed by Zelluna, the experimental therapy combines natural killer cells with engineered T-cell receptors to target the Mage-A4 protein found in several cancers. Its donor-derived, off-the-shelf design could make cell therapies faster, less expensive and more widely available, although its effectiveness remains under investigation.

Interim UK Health Security Agency estimates attribute 2,877 deaths to two 2026 heatwaves, nearly twice the total recorded across UK heatwaves in 2025 and approaching the annual record of 2,985 deaths set in 2022. Record temperatures, repeated heatwaves and drought conditions have increased pressure on hospitals, ambulance services and primary care, with officials warning that further hot weather could make 2026 the deadliest year for heat-associated deaths. Older adults and people with underlying health conditions are identified as particularly vulnerable.

Hospital admissions for ectopic pregnancies in England rose by about 3% annually between 2004 and 2012, stabilised until 2021, and then increased by more than 4% per year. University of Liverpool researchers linked the recent rise partly to delayed childbearing, while also citing changes in hospital management, infections, obesity and other environmental or lifestyle factors. Women aged 25 to 34 accounted for the largest share of admissions, but the proportion among women aged 40 and over rose from about 7% in 2013 to 12% in 2024. Women in the most deprived areas consistently had more than twice the admission rates for ectopic pregnancy and miscarriage than those in the least deprived areas, reflecting differences in smoking, obesity and access to early maternity care.

Nuffield Trust analysis shows that 43% of patients over 80 admitted to hospital in England waited more than 12 hours in A&E in 2025, compared with 19% of 21-to-30-year-olds. Experts say the disparity persists even when comparing patients who are ultimately admitted, challenging the assumption that older patients wait longer solely because they are more likely to need admission. The analysis links corridor care and long waits to insufficient hospital beds, delayed discharges and inadequate social care, while warning that an excessive focus on corridor-care targets could produce harmful incentives. The Royal College of Emergency Medicine called corridor care increasingly commonplace, and the Department of Health and Social Care cited a £450 million investment intended to expand capacity and reduce waits.

Nuffield Trust analysis shows that elderly patients, particularly those over 80, are much more likely than younger adults to wait over 12 hours for admission from A&E. In 2025, 43% of over-80s experienced such waits, compared with 19% of 21–30-year-olds, while nearly 3,000 patients a day in England received care in unsuitable corridors in May. Experts attribute the problem to insufficient hospital beds and inadequate social-care capacity, which delays discharges. The Department of Health and Social Care plans investment, but the Nuffield Trust warns that narrowly targeting corridor care could create unintended problems for patient flow.

Hospital admissions for ectopic pregnancies in England have risen by more than 4 percent annually since 2021, following an earlier increase between 2004 and 2012. University of Liverpool research suggests that older maternal age may be contributing to the trend, with the proportion of admissions involving women aged 40 and over rising from about 7 percent in 2013 to 12 percent in 2024. Women in England’s most deprived areas consistently face higher admission rates, potentially linked to greater smoking and obesity prevalence and reduced access to early maternity care.

More than 300,000 emergency contraceptive pills were supplied through high-street pharmacies in England during the first five months of a new NHS scheme. The initiative allows women to receive a confidential same-day consultation and prescription from a pharmacist or trained technician, avoiding the need for a GP appointment or sexual health clinic visit. NHS data show almost 305,000 pills were supplied between October 2025 and March, compared with fewer than 150,000 prescriptions from all sources during 2024/2025. Pharmacy teams can also advise on longer-term contraception, while health minister Gillian Merron said the scheme removes unnecessary barriers and costs.

More than 305,000 emergency contraceptive pills were supplied through NHS pharmacies in England during the first five months of a new scheme running from October 2025 to March 2026. The service enables women to obtain the pill through a confidential pharmacy consultation without a GP or sexual health clinic appointment, while also offering advice on longer-term contraception. NHS officials and health minister Gillian Merron said the scheme is improving access, particularly for women in deprived communities, and forms part of a wider expansion of community pharmacy support.

A King’s Fund study finds that England’s North–South life expectancy gap has widened, with a roughly three-year difference between London and the North East and little or no improvement in longevity across many northern regions over the decade to 2023–25. Men in the least deprived areas live about 10 years longer than those in the most deprived areas, while the healthy-life-expectancy gap reaches about 20 years. The report attributes northern disadvantages to deprivation and higher rates of preventable disease, suicide, and alcohol- and drug-related deaths, warning that the government’s targets appear unrealistic without unprecedented action. Andy Burnham’s launch of a government base in Manchester is presented alongside the government’s pledge to devolve power and reduce regional inequalities, while the Department of Health and Social Care says it is pursuing fairer GP funding and Neighbourhood Health Centres.

England’s North–South life expectancy divide has widened over the past decade, with people in London living around three years longer than those in the North East. Northern regions have seen little improvement, while London and southern areas have advanced despite record national life expectancy in 2025. Healthy life expectancy has fallen by about 2.5 years over the decade, with a gap of roughly two decades between the most and least deprived areas. The UK now ranks poorly among comparable high-income countries, prompting government efforts including Andy Burnham’s proposed decentralisation initiative in Manchester and further action from the Department of Health and Social Care.

A study of roughly 50,000 adults with type 2 diabetes found that GLP-1 drugs were associated with a 37% higher risk of alopecia than SGLT-2 inhibitors and a 68% higher risk than DPP-4 inhibitors. The association mainly involved non-scarring hair loss, which may be reversible. Researchers suggested that rapid weight loss, reduced calorie intake, nutritional deficiencies, and possible metabolic or hormonal effects could contribute, while stressing that more research is needed. UK regulators have received hundreds of hair-loss reports involving tirzepatide and semaglutide, and U.S. regulators are evaluating the potential safety signal.

The British Heart Foundation says that common “picky bits” such as sundried tomatoes, houmous, tzatziki, falafel and homemade salsa can contribute to the recommended five daily portions of fruit and vegetables. Four sundried tomatoes or three heaped tablespoons of houmous count as one portion, while beans and chickpeas count only once toward the daily total. Tzatziki and vegetable sticks can also help, although shop-bought salsa should be checked for high salt or sugar content.

England will expand newborn screening for spinal muscular atrophy through a national evaluation beginning in October, with all English screening laboratories expected to offer the heel-prick test by 2027. The rollout follows campaigning by Jesy Nelson and the SMA community after her twins were diagnosed with the condition. Earlier detection can enable treatment before irreversible motor-neuron loss, helping prevent severe disability and prolonging lives. Campaigners welcomed the decision as an end to the postcode lottery, while the evaluation will inform future UK screening recommendations; Scotland is also developing a similar programme.

England will begin rolling out a national newborn screening programme for Spinal Muscular Atrophy in October, with full implementation across UK screening laboratories expected by 2027. The simple heel-prick test is intended to enable earlier diagnosis and treatment, eliminating a postcode lottery in access to screening. Jesy Nelson, whose twins were diagnosed with SMA, led the campaign and welcomed the decision as a victory for affected families.

The UK Health Security Agency has warned people travelling abroad that mosquito-borne illnesses are increasing among UK travellers. Reported cases in England of Zika, dengue, chikungunya and malaria are outlined, with Indonesia, Thailand, the Maldives and Sri Lanka among the commonly linked destinations. Travellers are advised to seek destination-specific vaccine and medication guidance, use insect repellent, cover exposed skin, sleep under treated nets where necessary, and follow food and water hygiene precautions. Zika poses particular risks during pregnancy, while malaria can be fatal.

Mosquito-borne illnesses contracted abroad by UK travellers have increased, with Zika, dengue, chikungunya and malaria all showing higher case numbers compared with last year. The UK Health Security Agency warns travellers to use insect repellent, cover skin, sleep under treated nets, and follow food and water hygiene measures. Southeast and South Asia remain the most common sources of infection, and pregnant travellers are urged to seek medical advice due to additional risks.

NHS England plans to provide wearable technology to patients at high risk of sepsis, including some cancer patients, older people and people with serious mental illness. Watches and mobile-phone-linked devices could monitor vital signs such as blood pressure and heart rate, alerting clinicians to deterioration. The initiative aims to prevent around 1,000 deaths annually and contribute to a broader goal of reducing sepsis fatalities by 2035; sepsis currently causes about 4,000 deaths each year in England, with roughly a quarter considered preventable.

NHS England plans to trial wearable devices and mobile-phone technology for people at high risk of sepsis, monitoring vital signs such as heart rate, blood pressure, respiratory rate and temperature at home. The devices are intended to alert clinicians when patients deteriorate, enabling faster testing and treatment and potentially preventing 1,000 deaths annually. The strategy targets groups including immunosuppressed cancer patients, older people and those with catheters, while existing use at University College London Hospitals monitors CAR T-cell therapy patients for sepsis and cytokine release syndrome. The initiative responds to more than 118,000 emergency sepsis admissions in England in 2024/25 and evidence that delays in treatment substantially increase mortality.

Oxford University has begun human trials of a rapidly developed vaccine targeting the Bundibugyo strain of Ebola spreading in the Democratic Republic of Congo. The ChAdOx1 BDBV vaccine, based on the technology used for the Oxford/AstraZeneca Covid-19 vaccine, will be tested in 50 UK volunteers, with hundreds of thousands of doses already stockpiled for potential deployment. Researchers are preparing for further trials in Uganda as cases and deaths continue to rise, with no approved treatments currently available for this strain. Global health officials describe the vaccine’s swift progress as a crucial step toward containing one of the largest recorded Bundibugyo outbreaks.

The University of Oxford is beginning a Phase I trial of the ChAdOx1 BDBV Ebola vaccine in 50 healthy UK adults to assess its safety and immune response. The vaccine targets the Bundibugyo strain responsible for an outbreak in the Democratic Republic of the Congo and uses technology developed for the Oxford/AstraZeneca Covid-19 vaccine. More than 620,000 doses have been stockpiled, with further trials planned in Africa, while the strain remains without an approved vaccine or drug. The outbreak is reported to have caused more than 1,800 confirmed cases and 600 deaths.

Updated NHS exercise guidance highlights the health risks of prolonged sitting and emphasises that even small amounts of daily movement offer significant benefits. Chief medical officer Chris Whitty warns that remote work and online shopping reduce routine activity, urging adults to move regularly and strengthen muscles, particularly those using weight‑loss drugs. The guidelines outline activity recommendations for all age groups, stressing the value of incorporating movement into daily routines, and are supported by public health officials and organisations who note the broad physical and mental health advantages.

Updated UK exercise guidance stresses that any level of physical activity benefits health and highlights the dangers of prolonged sitting, even for those who meet recommended exercise levels. The recommendations urge at least 150 minutes of moderate weekly activity and emphasize muscle‑strengthening exercises, particularly for people using weight‑loss drugs due to risks of muscle loss. Chris Whitty notes that analysis of 30 million people shows consistent reductions in disease and mortality risk from increased activity.

A review published in the British Medical Journal found that most obesity drugs, including Wegovy and Mounjaro, do not significantly improve overall quality of life, despite promoting weight loss. Wegovy injections were the only treatment linked to lower risks of death, heart attack, and heart failure, with Mounjaro also reducing heart failure risk. The study noted an association between greater weight loss and increased side effects such as gastrointestinal problems and loss of lean muscle mass. Short trial durations limited conclusions on long‑term safety and health effects, underscoring the need for personalised treatment decisions.

A small study of 23 men found that sniffing dark chocolate with 90 percent cocoa significantly increased the number of leg extension repetitions participants could perform, while milk chocolate provided a smaller boost. The scents appeared to curb hunger and create psychological cues linked to fullness or reward without increasing perceived exertion.

A study from the University of Malaya found that sniffing dark chocolate reduces hunger and increases training volume in leg extension exercises, with dark chocolate scents producing the strongest effect. Milk chocolate also improved performance, though to a lesser degree. Researchers suggest the response stems from learned associations with food smells influencing appetite and perceived exertion.

A large review published in the British Medical Journal found that while many obesity drugs lead to significant weight loss, most—including Wegovy and Mounjaro—do not show clear improvements in overall quality of life or strong cardiovascular benefits within one year. Mounjaro and CagriSema produced the greatest weight reduction, though Mounjaro was also linked to the largest loss of lean muscle mass. Wegovy injections were the only treatment associated with reduced risks of death, heart attack, and heart failure. Evidence for several emerging drugs remains limited, and few treatments demonstrated kidney or quality‑of‑life benefits. Researchers and accompanying editorial authors emphasized the need for individualized treatment decisions and longer-term safety data.

The head of the NHS warned that any staff member who accesses patient medical records without a valid reason could face dismissal, regulatory referral or criminal prosecution. The statement follows investigations into multiple breaches, including staff accessing records of a child injured in a crocodile pit, recent misconduct cases at Cambridge and Nottingham hospital trusts, and an attempt to obtain and sell the Princess of Wales’s records. New NHS guidance emphasises lawful access, technical safeguards and employer responsibility to prevent misuse of confidential information.

Delayed discharges in the NHS have risen to nearly 13,000 per day, costing £2.7 billion annually as a lack of social care capacity and administrative challenges leave medically fit patients occupying hospital beds. The King’s Fund warns that these delays worsen A&E waiting times and contribute to widespread corridor care. Rising bed-day costs and pressure on NHS budgets accompany calls for government action to address social care shortcomings and reduce hospital demand through community-based care and public health measures. A national review of adult social care is underway to assess eligibility, costs and the role of the state in addressing long‑term systemic failings.

Researchers at King’s College London and McMaster University report that CAR‑T cell therapy engineered to target the GPNMB protein eliminated tumours in glioblastoma models by attacking both cancer cells and supportive macrophages. Experts note the therapy’s potential to improve survival for a cancer with extremely poor prognosis and call for greater investment, clinical trial capacity, and NHS readiness to deliver emerging treatments.

Dr Bill Kirkup resigned from the government‑commissioned review led by Baroness Valerie Amos after criticism of “normal birth ideology” was removed from the final report despite being included in an earlier approved draft. He argued that omitting the concerns overlooked ongoing patient‑safety risks. NHS England responded with a 10‑point plan to improve maternity services, while the government intends to appoint a national maternity commissioner, and independent reviews of poor care across several NHS trusts continue under Donna Ockenden.

A senior investigator, Dr Bill Kirkup, resigned from Baroness Valerie Amos’s government‑commissioned review into NHS maternity services after criticism of the push for normal births was removed from the final report. Kirkup argued that evidence of ongoing risks was excluded, creating a patient safety concern. Despite previous guidance discouraging targets limiting Caesarean sections and the Royal College of Midwives’ withdrawal of its normal birth campaign, Kirkup said the issue persists in some areas. NHS England released a plan to improve triage, staffing and clinical capacity, while recent reports highlighted serious failings at multiple hospital trusts. The government will appoint a national maternity commissioner to lead reforms.

A senior investigator resigned from Baroness Valerie Amos’s government-commissioned review of NHS maternity services, claiming criticism of a push for “normal birth” practices had been removed from the final report. Bill Kirkup argued that normal birth ideology remains a patient safety risk and said evidence of its persistence was excluded shortly before publication. NHS England has since outlined a 10‑point plan to improve triage, staffing, and escalation procedures across maternity services. Senior maternity leaders emphasised the need for reliable access to midwives and faster risk assessments, while recent reviews at multiple hospital trusts continue to highlight avoidable harm. The government plans to appoint a national maternity commissioner as recommended in the review.

A senior investigator resigned from a government‑commissioned review of NHS maternity services after criticism of “normal birth ideology” was removed from the final report. Bill Kirkup argued that evidence showed ongoing pressure to prioritise non‑intervention births, describing it as a patient‑safety risk. NHS England outlined a 10‑point plan to implement the review’s recommendations, including improved triage, dedicated midwifery staffing and clearer escalation routes. Leaders emphasised the need to modernise maternity services and prevent recurring failures as further investigations continue at multiple hospital trusts.

Bereaved families criticise Baroness Valerie Amos’s review of NHS maternity failings as insufficiently independent and lacking scrutiny of key regulators, renewing demands for a statutory public inquiry. They highlight the inclusion of NHS England and HSSIB staff in the investigation, the absence of analysis of regulators such as the GMC, NMC and CQC, and the report’s failure to address issues including normal birth ideology and post‑death care. Dr Bill Kirkup’s resignation from the review is linked to disagreements over the treatment of patient‑safety concerns. Families argue that hundreds of avoidable baby deaths have occurred while an inadequate review process proceeded and call for a full public inquiry to determine why systemic failures persist across maternity services.

The government will establish a national maternity commissioner after a review led by Valerie Amos found persistent failures in NHS maternity care, including systemic racism, discrimination, and poor listening to women. The review urges independent investigations for families, improved hospital culture, better teamwork, and round-the-clock senior cover in delivery units. The government plans to release a national action plan in December and add 1,000 temporary midwife posts, though advocacy groups argue the commissioner will lack meaningful independence and say the response misses key opportunities for improvement.

A government response to a review led by Baroness Valerie Amos includes appointing a national maternity commissioner and developing a maternity action plan after findings of widespread failures, discrimination, poor culture and inadequate oversight in NHS maternity services. The review cites systemic issues including racism, poor communication, workforce pressures and unsafe environments, while families reported avoidable harm and lack of accountability. Regulators are urged to treat discrimination as a safety issue and strengthen oversight. Recent findings at Nottingham University Hospitals NHS Trust underscore the scale of systemic failings. The government plans new standards, improved triage, enhanced regulatory coordination, anti-discrimination measures and expanded midwife support roles.

Families affected by NHS maternity failings criticise a new review led by Valerie Amos, arguing it lacks independence, overlooks key regulatory scrutiny, and fails to address the impact of normal birth ideology or post‑death care. The Maternity Safety Alliance calls the proposal for a national maternity commissioner dangerous, while Bill Kirkup resigned from the review over disagreements. The families renew demands for a statutory public inquiry, citing hundreds of avoidable baby deaths during what they describe as an inadequate investigation.

Rising temperatures and increased rainfall are creating conditions in the UK that may allow invasive mosquito species capable of spreading dengue, chikungunya and Zika to become established. An expert from the London School of Hygiene and Tropical Medicine warns that warming climate patterns could support dengue transmission in southern England by the 2060s. While malaria is not expected to become endemic, imported cases remain common. The public is advised to use repellents and protective clothing as climate change increases the likelihood of disease-carrying mosquitoes surviving in the UK.

Medical records of a three-year-old boy injured in a crocodile enclosure were accessed by 40 staff members at Cambridge University Hospitals, prompting the trust to report itself to the Information Commissioner’s Office and begin an internal investigation. The child remains in stable condition after being pulled from the enclosure at Johnsons of Old Hurst, where a 30-year-old man with learning difficulties was arrested and later bailed on suspicion of attempted murder. The hospital emphasised its strict confidentiality policies and potential disciplinary action for unauthorised access. Cambridgeshire Police confirmed the boy suffered serious injuries and was rescued by zoo staff, including Tracey Johnson.

Cambridge University Hospitals launched an investigation after about 40 staff accessed the medical records of a three-year-old boy seriously injured after allegedly being thrown into a crocodile enclosure at a Cambridgeshire zoo. The hospital referred the matter to the Information Commissioner’s Office and warned that any staff who viewed the records without a legitimate reason could face dismissal. The boy is in stable condition at Addenbrooke’s Hospital, while a man from Norfolk arrested on suspicion of attempted murder has been bailed due to being unfit for interview.

Record heat in the UK is creating ideal conditions for increased mosquito activity, with experts warning that climate change could allow disease‑carrying species such as the Asian tiger mosquito to become established in coming years. Modelling suggests London could support endemic dengue transmission by the 2060s. The public is urged to use insect repellent and protective clothing as the risk of mosquito‑borne illnesses may rise.

A UK heatwave combined with recent heavy rainfall has created conditions favorable for a surge in mosquitoes. Dr Mojca Kristan of the London School of Hygiene and Tropical Medicine warns that climate change may soon enable disease‑carrying species, including those capable of transmitting dengue and Zika, to establish in the UK, with modelling suggesting dengue could become endemic in London by the 2060s. While invasive species like the Asian tiger mosquito are not yet present, their eggs have been detected. People are advised to use repellent and wear protective clothing to reduce the risk of bites.

Inspectors found eight decomposed bodies at the Queen’s Medical Centre mortuary due to insufficient freezer capacity and inconsistent identification checks, creating a risk of releasing the wrong remains to funeral services. The findings included multiple critical and major failings, emerging soon after a separate review identified systemic failures and a toxic culture within the Nottingham University Hospitals NHS Trust. The trust’s chief executive apologised and announced an independently overseen action plan, while police arrested two men in connection with mortuary practices.

Inspectors found eight decomposing bodies and significant procedural failures in the mortuary services at Nottingham University Hospitals NHS Trust, citing insufficient freezer capacity, inadequate identification checks and inconsistent monitoring of deteriorating bodies. The findings followed a wider inquiry that documented extensive harm in the trust’s maternity services. Recent police arrests were linked to mortuary practices, and the trust’s chief executive acknowledged responsibility, outlining ongoing corrective actions under regulatory oversight.

Research involving more than 11,000 participants found that five‑minute walking breaks taken hourly can counter the health harms of prolonged sitting, improving mood and reducing fatigue without affecting work performance. Movement every 30 minutes produced slightly greater mood benefits, but hourly breaks offered the best balance of feasibility and health impact. Experts highlighted that prolonged sedentary time increases risks for chronic disease and early death, while short movement breaks help restore blood flow and metabolic activity. A cardiac nurse noted the heart‑health benefits but said longer‑term studies are needed due to the study’s reliance on self‑reported, short‑duration data.

A government-ordered review led by Donna Ockenden examines extensive maternity care failings at Nottingham University Hospitals NHS Trust, drawing on accounts from thousands of families and staff. Multiple cases of avoidable baby deaths, inadequate investigations, and long-standing staffing concerns are detailed, alongside ongoing criminal, regulatory, and professional inquiries. Families affected by stillbirths and neonatal deaths describe systemic denial of responsibility and profound personal impact. Regulatory bodies are reviewing numerous fitness-to-practice cases, and the trust has previously faced significant fines for unsafe care. The findings are expected to prompt stronger accountability measures across the NHS.

An upcoming review led by Donna Ockenden is expected to outline major failures within Nottingham University Hospitals NHS Trust’s maternity services, linked to numerous baby deaths and preventable harm. The inquiry, prompted by a 2020 investigation and involving thousands of families and staff, coincides with a corporate manslaughter investigation by Nottinghamshire Police and regulatory probes by the GMC and NMC. Bereaved families continue to seek accountability and a statutory public inquiry into systemic failings in maternity care.

Research shows that taking five‑minute walking breaks every hour can counteract the health risks of prolonged sitting, improving mood and reducing fatigue without harming work performance. These short activity intervals offer an achievable way to reduce sedentary time, a major public health concern in high‑income countries.

A review of 85 trustworthy clinical trials found that most IVF add-ons, including acupuncture, corticosteroids, endometrial receptivity testing, intralipid infusion, platelet-rich plasma and pre-implantation genetic testing, showed no benefit or produced inconclusive results. Weak evidence suggested possible benefits from EmbryoGlue and endometrial scratching, while PICSI may reduce miscarriage but has not been shown to improve live birth rates. Researchers warned that commercial clinics, forums and social media can overstate benefits, creating false hope, unnecessary procedures and financial strain for patients. A separate Australian study found that patients often rely on clinic websites and social media for IVF information, while an evidence-based, non-commercial website improved their understanding and satisfaction.

A review of 85 clinical trials published in The Lancet found that most IVF add‑on treatments provide no proven fertility benefit and may create false hope, unnecessary procedures and financial strain. Only weak evidence supported minor potential benefits for EmbryoGlue, endometrial scratching and PICSI, with no robust improvement in live‑birth rates. Researchers warned that commercialised IVF clinics and online forums often overstate the value of add‑ons, contributing to widespread misinformation. A companion study showed most IVF patients rely heavily on clinic websites and social media for guidance, reinforcing the need for unbiased, evidence‑based information.

NICE has approved the immune‑modulating drug teplizumab, allowing its use on the NHS for people aged eight and over with early-stage type 1 diabetes. The treatment, delivered through a single 14‑day course of infusions, can delay the onset of symptomatic disease by nearly three years. Around 1,100 people are expected to be eligible in the first year. Diabetes UK called the approval a landmark step, with further studies underway to identify individuals who could benefit.

Teplizumab, a Sanofi-made immunotherapy that can delay the onset of type 1 diabetes by up to three years, has been approved for NHS use by the National Institute for Health and Care Excellence. The treatment, already used in the US, is intended for adults and children aged eight and over with early-stage type 1 diabetes and works by retraining the immune system to stop attacking pancreatic cells. Diabetes UK and NICE leaders describe the approval as a major milestone, emphasising its value in providing patients more time before needing full insulin management. Ongoing UK screening studies aim to identify eligible individuals earlier, and families who have already accessed the drug highlight the benefits of added time before intensive diabetes care is required.

Two men were arrested on suspicion of misconduct in public office over mortuary service practices at Nottingham University Hospitals NHS Trust as part of a wider investigation into serious maternity care failures. The arrests, linked to breaches of Human Tissue Act regulations, come ahead of the release of an independent review led by Donna Ockenden. Police have begun notifying affected families, while related investigations by medical regulatory bodies and a corporate manslaughter inquiry continue.

Two men were arrested on suspicion of misconduct in public office over operating practices in mortuary services at Nottingham University Hospitals NHS Trust, which is central to a major maternity services inquiry. Police cited breaches of Human Tissue Act regulations discovered during Operation Perth, the ongoing investigation into maternity failings. Families affected by the issues were notified ahead of the release of the independent review led by Donna Ockenden. The trust has previously paid substantial compensation, while regulators and police continue broader investigations, including a corporate manslaughter case.

New research from Queen Mary University of London indicates the HPV vaccine has prevented nearly 200 cervical cancer deaths in England, with women vaccinated at ages 12 to 13 facing almost no risk of dying from the disease before age 30. Between 2020 and 2024, England recorded no cervical cancer deaths among women aged 20 to 24, a first since the vaccine’s introduction. Despite the success, falling vaccination rates have raised concerns, with uptake below the World Health Organisation’s 90 percent target and lowest in London. Health leaders urged renewed public health efforts to boost vaccination and screening participation as the NHS aims to eliminate cervical cancer by 2040.

A large study funded by Cancer Research UK found that cervical cancer deaths among women aged 20 to 24 in England fell to zero between 2020 and 2024 following widespread HPV vaccination. The vaccine is estimated to have prevented about 200 deaths, with risk of dying from cervical cancer before age 30 nearing zero for those vaccinated at ages 12 to 13. Researchers warn that falling vaccination rates, well below the World Health Organisation’s 90 percent target, threaten future progress, prompting calls for increased uptake, especially in under‑served communities.

NHS England reported a significant drop in A&E attendances during England’s Euro 2024 matches, particularly in the hour before kick-off, with subsequent surges in overnight demand driven largely by trauma-related injuries. Ahead of the 2026 World Cup, the service urges fans not to postpone seeking medical care during matches and to avoid activities that could lead to injury after games.

Emergency department visits dropped significantly during England’s Euro 2024 matches, with nearly 17,000 fewer attendances than expected and reductions of up to 11 percent before kick-offs. NHS England warns fans not to delay seeking urgent care, noting a surge in patients after matches along with increased trauma-related cases. Officials urge the public to use emergency and non-emergency services as usual throughout the World Cup period and avoid behaviour that could result in injuries.

A one‑off vaccination programme will offer two doses of the MenB vaccine to around one million people at highest risk of meningitis B, focusing on Year 13 pupils and those under 25 starting university or residential further education this autumn. The initiative follows several outbreaks in Kent, Dorset and Reading, with health officials identifying 18‑year‑olds and new university students as the most vulnerable due to increased social mixing. Eligible individuals will receive the GSK Bexsero vaccine, with appointments beginning in July and full protection requiring two doses given four weeks apart. The programme excludes older students, postgraduates and those not entering higher education for the first time.

Severe lupus patients in a UK NHS trial experienced rapid and sustained remission after receiving CAR T‑cell therapy, marking the first time this treatment has been used for lupus in the country. Five of six patients treated with a lower dose showed significant recovery, including improvements in kidney, heart, and lung function, enabling them to discontinue long‑term medications. The therapy, using the engineered product obe‑cel developed by Autolus Therapeutics, appears to reset the immune system by depleting disease‑causing B cells and allowing healthier cells to repopulate. Researchers from UCLH and UCL describe the results as a major step toward potentially curing autoimmune diseases, with broader implications for conditions such as multiple sclerosis. The findings were presented at the EULAR European Congress of Rheumatology.

Around one million Year 13 students and people under 25 entering university or residential further education will be offered a two‑dose Meningitis B vaccination programme following recent outbreaks, including fatal cases in Kent. First doses will be available from 20 July with the second in August, spaced at least 28 days apart. Eligible students will be contacted by the NHS, while others under 25 can book through pharmacies, with the health secretary urging uptake for protection ahead of the academic year.

The UK medicines regulator approved Wegovy, the first GLP‑1 daily weight‑loss pill, for obese or overweight adults with related health conditions. The semaglutide tablet is taken in gradually increasing doses up to 25mg and showed an average 17% body‑weight reduction over 64 weeks when combined with diet and exercise. The drug will be available privately soon but has not yet been evaluated for NHS use.

More than 40 captive-bred hazel dormice were released into ancient woodland on the Bradgate Park Trust estate in Leicestershire to strengthen the county’s only dormouse population. The initiative, led by the People’s Trust for Endangered Species, responds to a national decline of over 70 percent in dormouse numbers due to habitat loss and hedgerow degradation. The release is part of a long‑running programme that has reintroduced over 1,160 dormice to 27 woodlands across 14 counties since 1993.

Severe lupus patients in the UK achieved remission after a single-dose CAR T‑cell therapy used for the first time on the NHS. The treatment genetically reprograms a patient’s immune cells to target harmful cells, with five of six trial participants responding within months. Led by UCLH and UCL, the findings indicate a potential immune reset and possible cure, though broader studies are required.

The government will offer two doses of the meningitis B vaccine to around one million young people aged 17 to 18 and those under 25 entering university or residential further education following deadly outbreaks, including a major cluster in Kent. Health officials cite heightened risk among students living in close quarters and note that recent clusters suggest a shift in MenB transmission patterns. The programme begins in July, with second doses in August or September, and is intended to reduce severe illness ahead of the academic year. Experts highlight low immunity levels as a possible factor in rising cases, while charities welcome the initiative but call for a broader, permanent vaccination programme.

More than 40 hazel dormice were released into ancient woodland at Bradgate Park in Leicestershire as part of a national conservation programme led by the People’s Trust for Endangered Species. The effort follows a successful 2025 reintroduction that established the county’s only known population, which has since shown signs of breeding and population growth. Additional releases aim to strengthen genetic diversity and expand the species’ presence across the National Forest. The dormice, bred in captivity and health‑checked before release, are introduced through controlled enclosures to help them acclimatise. Since 1993, the programme has released over 1,100 dormice across Britain.

The UK medicines regulator approved the country’s first GLP‑1 weight‑loss pill, a daily semaglutide tablet sold as Wegovy, for adults with obesity or certain weight‑related conditions. Trial data showed an average 17 percent weight loss among those who remained on treatment. The drug will be available privately within weeks but has not yet been assessed for NHS use. Experts note strong demand and suggest that the pill could expand access for people who prefer oral medication over injections.

Two children in England have died from measles this year as cases rise to 736, with outbreaks concentrated among unvaccinated young children in London and the West Midlands. Health officials warn of severe complications and emphasise that measles is highly contagious, while the WHO no longer classifies the UK as having eliminated the disease. Symptoms typically appear one to two weeks after exposure and include fever, rash, cough, conjunctivitis and a runny nose.

Two children in England have died from measles as cases rise to 736 this year, with outbreaks concentrated in London and the West Midlands. Health officials report most infections involve unvaccinated children aged 10 and under, and the UK is no longer considered measles‑free. UKHSA and government leaders urge parents to ensure children receive MMR or MMRV vaccinations to protect them and vulnerable groups. The article outlines how measles spreads, its symptoms and the potential for severe complications, including brain inflammation, pneumonia and long‑term neurological disease.

The UK government is investing £20 million to deploy AI technology across NHS trusts by 2029 to accelerate cancer diagnosis through chest X-rays, along with an £8 million pilot to speed care for conditions such as heart failure, strokes and lung cancer. Existing AI use has already cut lung cancer scan analysis time in half, helping radiologists deliver quicker diagnoses. Health Secretary James Murray said the tools reduce waiting times and enable earlier treatment, while leading cancer charities welcomed the initiative for improving outcomes and reducing patient anxiety.

The UK government is investing £20 million to expand AI analysis of chest X‑rays across all NHS trusts in England by 2029, with an additional £8 million pilot across 13 organisations to speed diagnosis of conditions including lung cancer, heart failure and stroke. Ministers and health leaders highlight reduced scan turnaround times and faster access to treatment, while medical organisations emphasise AI’s role in supporting rather than replacing radiologists. Patient testimony underscores quicker diagnosis and improved outcomes enabled by the technology.

NHS England will introduce Stereotactic Ablative Radiotherapy for men with early prostate cancer, reducing treatment from more than 20 sessions to five over two weeks. All radiotherapy centres in England will offer the treatment within three months, potentially benefiting about 17,500 eligible patients annually and freeing up roughly 50,000 treatment appointments each year.

A highly targeted form of radiotherapy known as stereotactic radiotherapy will be offered across all NHS radiotherapy centres in England, reducing treatment sessions for early prostate cancer from more than 20 to five. NHS leaders highlight improved outcomes, fewer side effects, and reduced hospital visits, with an estimated 17,500 men potentially eligible each year. The rollout is expected to free up around 50,000 appointments annually. Prostate Cancer UK welcomes the development, emphasising the reduced burden on patients and ongoing research to widen eligibility.

A new mRNA vaccine developed by the University of Oxford and Moderna will enter trials to prevent colorectal and ovarian cancers in people with Lynch syndrome. The Intercept-Lynch trial will test immune responses, dosing and safety, with a second phase expanding across UK centres from 2027. Researchers aim to train the immune system to recognise and eliminate precancerous cells caused by Lynch-related mutations. Experts suggest the approach could offer broad, lifelong protection for patients and inform future preventive cancer vaccines. Cancer Research UK supports the project, and Moderna emphasises the potential of early immune intervention.

Oxford University and Moderna are beginning trials of an mRNA-based vaccine designed to prevent cancer in people with Lynch syndrome by training the immune system to eliminate precancerous cells. The first phase will test safety, dosage and immune response, with a second phase planned for 2027, and researchers believe the approach could later be adapted to other cancer types.

Hundreds of serious and preventable medical incidents were recorded across the NHS in the year up to March, including 166 wrong-site surgeries, 121 cases of foreign objects left inside patients, and 50 wrong implants or prostheses. Additional errors involved incorrect medication routes, insulin overdoses, blood-type mismatches, and safety failures such as falls and accidental air administration instead of oxygen, underscoring systemic weaknesses in patient safety protocols.

Data from NHS England reports 403 preventable patient safety incidents over the past year, including 166 cases of wrong‑site surgery and 121 cases of foreign objects left inside patients. Additional errors involved incorrect implants, improper medication routes, insulin overdoses, and patients receiving the wrong blood type. The number of incidents matches the previous year. An NHS spokesperson said investigations and improvements follow each event to reinforce patient safety.

Research shows that structural changes in lymph nodes, particularly involving fibroblastic reticular cells, can signal the likelihood of breast cancer spreading before cancer cells appear. Certain changes correlate with better or worse survival, supporting more personalised treatment and potentially reducing unnecessary lymph node removal. Funding from Breast Cancer Now supports development of targeted therapies and improved risk identification.

Researchers have identified structural changes in lymph nodes that can predict the likelihood of breast cancer spreading, offering potential for more personalised treatments and reducing unnecessary lymph node removal. The study found that the fibroblastic reticular cell network alters before cancer becomes visible and varies by cancer type, spread and prior treatment. These insights may guide new therapies and limit complications such as lymphoedema. The research, involving 331 lymph node samples, was conducted by teams at King’s College London and University College London and funded by Breast Cancer Now.

Research involving more than 13,000 women around age 72 shows that walking at least 4,000 steps on one or two days a week reduces the risk of early death and heart disease by more than a quarter, challenging the standard goal of 10,000 steps per day. Greater step counts provide additional but modest benefits, and overall activity volume matters more than how frequently steps are accumulated. Findings suggest physical activity guidelines for older women should recommend a minimum of 4,000 steps per day on at least one or two days each week.

A five-year-old girl suffered pain and bleeding after a physician associate without prescribing rights issued a vaginal pessary unsuitable for children, and a pharmacy failed to challenge the prescription. The condition was later correctly identified as vulvovaginitis. The incident led to scrutiny of the mother over suspected abuse and prompted procedural changes at the GP practice and pharmacy, with guidance from the Royal College of GPs advising against PAs treating children under 16.

A five-year-old girl suffered bleeding, severe pain, and trauma after being wrongly prescribed a clotrimazole vaginal pessary and cream by a physician associate whose decision was not reviewed by a doctor. The health ombudsman found multiple failures involving the GP practice and pharmacy, including inadequate supervision, poor communication, and missed safeguards. The misprescription led to unnecessary safeguarding concerns before a consultant identified the true cause of the symptoms. The GP practice and pharmacy have since taken corrective actions, while broader concerns continue regarding the role and oversight of physician associates in patient care.

A Care Quality Commission report found that midwives at Oxford University Hospitals NHS Foundation Trust were instructed to work double shifts without sleep, leaving some awake for more than 24 hours and increasing risks to patient safety. Inspectors cited failures in triaging pregnant women within recommended time limits, inaccurately reported delays to labour induction, and inadequate staffing that compromised privacy and dignity for bereaved women. While overall maternity services at John Radcliffe and Horton General hospitals were upgraded to a ‘good’ rating, safety at John Radcliffe remained rated as ‘requires improvement’.

Inspectors found midwives at Oxford University Hospitals NHS Foundation Trust were sometimes required to work more than 24 hours without rest as community staff were redeployed to cover hospital shortages. The Care Quality Commission reported failures in timely triage, significant delays in induction of labour that were underreported, and inadequate environments for bereaved women. While overall maternity services at both John Radcliffe and Horton General hospitals were rated good, safety at the John Radcliffe unit still required improvement due to inconsistent systems under pressure. Trust leadership acknowledged the issues and committed to urgent corrective action.

Experts warned that unsafe beauty products, particularly UV nail gels imported from China, skin lighteners, and a frog‑secretion cream known as Kambo, are being sold through major online marketplaces. A trading standards representative criticised Amazon for failing to vet overseas sellers, while regulatory officials countered that daily enforcement actions are taken to remove unsafe items. MPs highlighted conflicting evidence over the effectiveness of oversight and the responsibility of marketplaces in preventing harmful imports.

A long-term study involving more than 147,000 participants found that 90 minutes to two hours of weekly strength training reduces the risk of premature death, including from heart disease, stroke and neurological conditions. The greatest benefits occur when strength training is combined with high levels of aerobic activity. Current NHS guidelines support regular strength and moderate-to-vigorous aerobic exercise. Experts emphasize simple routines, proper technique, gradual progression, and adequate recovery, nutrition and hydration to maximise health gains and support healthy ageing.

British surgeons warn that medical tourism for leg‑lengthening procedures is creating a growing strain on the NHS as patients return with severe complications including implant failure, poor bone healing and deformities. A study from the Royal National Orthopaedic Hospital NHS Trust reports significant treatment costs and indicates the true financial impact is likely much higher. Social media influence, lower prices abroad and the appeal of combining surgery with a holiday drive patients to seek treatment overseas despite substantial risks. The Royal College of Surgeons of England urges improved public awareness and better data collection to understand the scale of complications from overseas procedures.